Exploring the viability of Zeatin as a prospective therapeutic candidate for investigating the complex interplay between severe acute respiratory syndrome coronavirus (SARS-CoV) and Alzheimer’s disease

被引:0
|
作者
A. S. Sriranjini
Ashish Thapliyal
Kumud Pant
机构
[1] Graphic Era Deemed to be University,Department of Biotechnology
关键词
SARS-CoV; COVID; Alzheimer’s; Pharmacology; APOE4; ACE2; SPIKE;
D O I
10.1007/s40203-024-00195-3
中图分类号
学科分类号
摘要
The present research aims to explore the intricate link between SARS-CoV infection and susceptibility to Alzheimer’s disease, focusing on the role of APOE4, a genetic factor associated with both conditions. Our research aims to uncover shared molecular pathways, considering APOE4’s impact on lipid metabolism, immune responses, and neuroinflammation relevant to COVID-19 and AD. The Chyawanprash phytocompounds were subjected to in-silico ADMET profiling and Zeatin a neuroprotective cytokinin emerged as a promising regulator of the ACE2-SPIKE complex as it exhibits favourable pharmacological attributes, presenting as a non-substrate for Permeability glycoprotein, low Protein Binding Percentage, and distinctive toxicity endpoints. Therapeutic candidate. Zeatin’s robust binding disrupts the intricate APOE4-ACE2-SPIKE interplay (AAS), offering a potential therapeutic avenue that is further corroborated by Molecular dynamic simulation as the system remained stable without any major fluctuation throughout the 100ns simulation. The AAS binding free energy, determined as -124.849 +/- 15.513 KJ/mol using MMPBSA assay, reveals significant contributions to complex stability from amino acids including, GLN41: 1.211 kcal/mol, GLU340: 1.188 kcal/mol, ALA344: 1.198 kcal/mol, while ARG38: 2.011 kcal/mol establishes pivotal strong bonds integral to the interaction between AAS and Zeatin. Rigorous cytotoxicity assessments reveal Zeatin’s safety profile, highlighting its inhibitory effect on LN18 cell viability that sharply decreases to 32.47% at 200 µg/ml, underscoring its modulatory impact on cellular metabolism. These findings enhance our understanding of the convergent mechanisms linking SARS-CoV and AD, providing valuable insights for potential therapeutic interventions. Further research is warranted to elucidate the specific pathways and molecular mechanisms through which zeatin exerts its protective effects.
引用
收藏
相关论文
共 50 条
  • [1] Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
    Darnell, MER
    Subbarao, K
    Feinstone, SM
    Taylor, DR
    JOURNAL OF VIROLOGICAL METHODS, 2004, 121 (01) : 85 - 91
  • [2] SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) : METHODS OF DIAGNOSIS AND TREATMENT
    Bhargava, Shivanshi
    Singh, Aditi
    EVERYMANS SCIENCE, 2020, 54 (06): : 361 - 367
  • [3] Synthetic peptide studies on severe acute respiratory syndrome coronavirus (SARS-CoV)
    Chu, LHM
    Choy, WY
    Waye, MMY
    Ngai, SM
    FEBS JOURNAL, 2005, 272 : 140 - 141
  • [4] Molecular Advances in Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)
    Raymond Kin Hi Hui
    Raymond Tsz Yeung Wong
    Chi Wai Yip
    Frederick Chi Ching Leung
    Genomics Proteomics & Bioinformatics, 2003, (04) : 247 - 262
  • [5] Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): In search of potent SARS-CoV entry inhibitors
    Chu, Ling-Hon Matthew
    Chan, Siu-Hong
    Tsai, Sau-Na
    Wang, Yi
    Cheng, Christopher Hon-Ki
    Wong, Kam-Bo
    Waye, Mary Miu-Yee
    Ngai, Sai-Ming
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (06) : 2335 - 2347
  • [6] Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
    Yasui, Fumihiko
    Kai, Chieko
    Kitabatake, Masahiro
    Inoue, Shingo
    Yoneda, Misako
    Yokochi, Shoji
    Kase, Ryoichi
    Sekiguchi, Satoshi
    Morita, Kouichi
    Hishima, Tsunekazu
    Suzuki, Hidenori
    Karamatsu, Katsuo
    Yasutomi, Yasuhiro
    Shida, Hisatoshi
    Kidokoro, Minoru
    Mizuno, Kyosuke
    Matsushima, Kouji
    Kohara, Michinori
    JOURNAL OF IMMUNOLOGY, 2008, 181 (09): : 6337 - 6348
  • [7] Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection
    Delgado-Roche, Livan
    Mesta, Fernando
    ARCHIVES OF MEDICAL RESEARCH, 2020, 51 (05) : 384 - 387
  • [8] Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV)
    Lee, YS
    Chen, CH
    Chao, A
    Chen, ES
    Wei, ML
    Chen, LK
    Yang, KDD
    Lin, MC
    Wang, YH
    Liu, JW
    Eng, HL
    Chiang, PC
    Wu, TS
    Tsao, KC
    Huang, CG
    Tien, YJ
    Wang, TH
    Wang, HS
    Lee, YS
    BMC GENOMICS, 2005, 6 (1)
  • [9] Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV)
    Yun-Shien Lee
    Chun-Houh Chen
    Angel Chao
    En-Shih Chen
    Min-Li Wei
    Lung-Kun Chen
    Kuender D Yang
    Meng-Chih Lin
    Yi-Hsi Wang
    Jien-Wei Liu
    Hock-Liew Eng
    Ping-Cherng Chiang
    Ting-Shu Wu
    Kuo-Chein Tsao
    Chung-Guei Huang
    Yin-Jing Tien
    Tzu-Hao Wang
    Hsing-Shih Wang
    Ying-Shiung Lee
    BMC Genomics, 6
  • [10] A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV)
    Rashed Noor
    Archives of Microbiology, 2021, 203 : 1943 - 1951